» Articles » PMID: 38474423

Lysosomes in Cancer-At the Crossroad of Good and Evil

Overview
Journal Cells
Publisher MDPI
Date 2024 Mar 13
PMID 38474423
Authors
Affiliations
Soon will be listed here.
Abstract

Although it has been known for decades that lysosomes are central for degradation and recycling in the cell, their pivotal role as nutrient sensing signaling hubs has recently become of central interest. Since lysosomes are highly dynamic and in constant change regarding content and intracellular position, fusion/fission events allow communication between organelles in the cell, as well as cell-to-cell communication via exocytosis of lysosomal content and release of extracellular vesicles. Lysosomes also mediate different forms of regulated cell death by permeabilization of the lysosomal membrane and release of their content to the cytosol. In cancer cells, lysosomal biogenesis and autophagy are increased to support the increased metabolism and allow growth even under nutrient- and oxygen-poor conditions. Tumor cells also induce exocytosis of lysosomal content to the extracellular space to promote invasion and metastasis. However, due to the enhanced lysosomal function, cancer cells are often more susceptible to lysosomal membrane permeabilization, providing an alternative strategy to induce cell death. This review summarizes the current knowledge of cancer-associated alterations in lysosomal structure and function and illustrates how lysosomal exocytosis and release of extracellular vesicles affect disease progression. We focus on functional differences depending on lysosomal localization and the regulation of intracellular transport, and lastly provide insight how new therapeutic strategies can exploit the power of the lysosome and improve cancer treatment.

Citing Articles

Potential Modulatory Role of Phoenixin-14 in Epithelial-Mesenchymal Transition of Endometriotic 12Z Cells.

Kulinska K, Wierzbicka M, Dera-Szymanowska A, Szymanowski K, Andrusiewicz M, Wolun-Cholewa M Biomedicines. 2025; 13(1).

PMID: 39857742 PMC: 11762346. DOI: 10.3390/biomedicines13010158.


Non-Canonical, Extralysosomal Activities of Lysosomal Peptidases in Physiological and Pathological Conditions: New Clinical Opportunities for Cancer Therapy.

Conesa-Bakkali R, Morillo-Huesca M, Martinez-Fabregas J Cells. 2025; 14(2).

PMID: 39851495 PMC: 11763575. DOI: 10.3390/cells14020068.


NKX3-2 Induces Ovarian Cancer Cell Migration by HDAC6-Mediated Repositioning of Lysosomes and Inhibition of Autophagy.

Ferraresi A, Ghezzi I, Salwa A, Esposito A, Dhanasekaran D, Isidoro C Cells. 2024; 13(21.

PMID: 39513923 PMC: 11544992. DOI: 10.3390/cells13211816.


Lysosome-Associated Membrane Protein-3 (LAMP3) Expression in Oral Squamous Cell Carcinoma and Its Relationship With Clinicopathological Parameters: A Cross-Sectional Study.

Jeyapriya M, Kumar S, Nirmal M Cureus. 2024; 16(9):e69790.

PMID: 39429383 PMC: 11491047. DOI: 10.7759/cureus.69790.

References
1.
Braulke T, Bonifacino J . Sorting of lysosomal proteins. Biochim Biophys Acta. 2008; 1793(4):605-14. DOI: 10.1016/j.bbamcr.2008.10.016. View

2.
Janda E, Nevolo M, Lehmann K, Downward J, Beug H, Grieco M . Raf plus TGFbeta-dependent EMT is initiated by endocytosis and lysosomal degradation of E-cadherin. Oncogene. 2006; 25(54):7117-30. DOI: 10.1038/sj.onc.1209701. View

3.
Latifkar A, Ling L, Hingorani A, Johansen E, Clement A, Zhang X . Loss of Sirtuin 1 Alters the Secretome of Breast Cancer Cells by Impairing Lysosomal Integrity. Dev Cell. 2019; 49(3):393-408.e7. PMC: 6519475. DOI: 10.1016/j.devcel.2019.03.011. View

4.
Hong S, Oh H, Valera V, Baba M, Schmidt L, Linehan W . Inactivation of the FLCN tumor suppressor gene induces TFE3 transcriptional activity by increasing its nuclear localization. PLoS One. 2011; 5(12):e15793. PMC: 3012117. DOI: 10.1371/journal.pone.0015793. View

5.
Debnath J, Gammoh N, Ryan K . Autophagy and autophagy-related pathways in cancer. Nat Rev Mol Cell Biol. 2023; 24(8):560-575. PMC: 9980873. DOI: 10.1038/s41580-023-00585-z. View